22270 ⎘
Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action Inhibitors, antagonists
Sub-classes:IMPLANTABLE DRUG-DEVICE COMBINATIONS, AND RELATED METHODS OF TREATMENT
#2SPRAYABLE POLYMERIC SCAFFOLD LOADED WITH INFLAMMASOME-INHIBITING LIPID NANORODS FOR ANTI-INFLAMMATION THERAPY
#3METHODS OF ALTERING BONE GROWTH BY ADMINISTRATION OF SOST OR WISE ANTAGONIST OR AGONIST
#4WNT-MODULATING GENE SILENCERS AS BONE ANABOLIC THERAPY FOR OSTEOPOROSIS AND CRITICAL-SIZED BONE DEFECT
#5THERAPEUTIC BIOMATERIAL THAT ATTENUATES THE FOREIGN BODY RESPONSE
#6COMPOSITIONS COMPRISING A BIOABSORBABLE POLYMER AND METABOLIC INHIBITOR
#7METHODS OF ALTERING BONE GROWTH BY ADMINISTRATION OF SOST OR WISE ANTAGONIST OR AGONIST
#8Platelet Adhesion Reduction Cardiovascular Graft
#9METHODS AND COMPOSITIONS FOR THE TREATMENT OF IMPLANT ASSOCIATED COMPLICATIONS
#10Methods of altering bone growth by administration of Sost or Wise antagonist or agonist
#11Methods of altering bone growth by administration of Sost or Wise antagonist or agonist
#12HEMOSTATIC DEVICES
#13COATING FOR INTRALUMINAL EXPANDABLE CATHETER PROVIDING CONTACT TRANSFER OF DRUG MICRO-RESERVOIRS
#14MACROPHAGE DIVERSITY IN REGENERATIVE, FIBROTIC BIOMATERIAL ENVIRONMENTS
#15COMPOSITIONS AND METHODS TO PROMOTE WOUND HEALING
#16COMPOSITION FOR IMPROVED BONE FRACTURE HEALING
#17CYCLOOXYGENASE INHIBITOR AND CALCIUM CHANNEL ANTAGONIST COMPOSITIONS AND METHODS FOR USE IN UROLOGICAL PROCEDURES
#18TUBULAR NONWOVEN STRUCTURE AS ACTIVE AGENT CARRIER FOR THE ATRAUMATIC TREATMENT OF HOLLOW ORGANS, AND A PROCESS FOR PRODUCING THE SAME
#19Rho kinase inhibitor releasing implants and related methods of use
#20CYCLOOXYGENASE INHIBITOR AND CALCIUM CHANNEL ANTAGONIST COMPOSITIONS AND METHODS FOR USE IN UROLOGICAL PROCEDURES
#21Peptidic TGF-beta antagonists
#22Hemostatic devices
#23Method of using a cardiovascular graft to reduce thrombosis or platelet adhesion
#24Intraocular lens implant
#25DEVICE AND METHOD FOR PROMOTING RAPID STRUT COVERAGE AND VASCULAR ENDOTHELIAL COVERAGE
#26METHODS AND COLLAGEN PRODUCTS FOR TISSUE REPAIR
#27COMPOSITIONS AND METHODS TO PROMOTE WOUND HEALING
#28METHODS AND COLLAGEN PRODUCTS FOR TISSUE REPAIR
#29Methods of improving cell-based therapy
#30Compositions and methods of modulating endochondral ossification and bone formation
#31MEDICAL DEVICES
#32Controlled and precise treatment of cardiac tissues
#33Intraocular filter device and methods of using same
#34Peptidic TGF-beta antagonists
#35Cyclooxygenase Inhibitor and Calcium Channel Antagonist Compositions and Methods for Use in Urological Procedures
#36Coating for intraluminal expandable catheter providing contact transfer of drug micro-reservoirs
#37Drug eluting stent
#38MOLECULAR TARGETS FOR THE TREATMENT OF WOUNDS, IN PARTICULAR CHRONIC WOUNDS
#39METHODS AND COLLAGEN PRODUCTS FOR TISSUE REPAIR
#40Methods of improving cell-based therapy
#41NANOPARTICLE-MEDICATED GENETIC DELIVERY OF GROWTH INHIBITING GENES ON BALLOON ANGIOPLASTY TO SUPPRESS INTIMAL HYPERPLASIA
#42IMMUNOCONJUGATES FOR PROGRAMMING OR REPROGRAMMING OF CELLS
#43Compositions and methods to promote wound healing
#44Promotion of Wound Healing
#45Molecular targets for the treatment of wounds, in particular chronic wounds
#46Medical devices
#47Hemostatic devices
#48Method of producing a 3D subject specific biomimetic nerve conduit
#49Device and formulation for topical treatment of pain affecting the vulvar area of the female human genital organ
#50Methods of altering bone growth by administration of Sost or Wise antagonist or agonist
#51Osteogenic regenerative scaffold matrix composition
#52VHH for application in tissue repair, organ regeneration, organ replacement and tissue engineering
#53Cyclooxygenase inhibitor and calcium channel antagonist compositions and methods for use in urological procedures
#54Compositions and methods for treating and preventing neointimal stenosis
#55Wnt/beta-catenin inhibitor-eluting endovascular stent
#56Methods and products for tissue repair
#57Hemostatic devices
#58Pharmaceutical compositions containing hyaluronic acid for use in the treatment of black disc disease
#59METHODS OF IMPROVING CELL-BASED THERAPY
#60Devices and methods for the prevention and treatment of neuromas
#61MEDICAL DEVICE WITH COATING THAT PROMOTES ENDOTHELIAL CELL ADHERENCE
#62Medical device with coating that promotes endothelial cell adherence
#63Medical devices
#64Controlled release of growth factors and signaling molecules for promoting angiogenesis
#65Device for coating a stent and associated coating method and stent produced according to the method
#66Biomimetic coating of magnesium alloy for enhanced corrosion resistance and calcium phosphate deposition
#67Compositions and methods for treating and preventing neointimal stenosis
#68Formulation for preventing or reducing bleeding at a surgical site
#69Noggin inhibitory compositions for ossification and methods related thereto
#70Composition for active principles delivery containing a fatty acid excipient
#71Methods and products for tissue repair
#72Product and process for inhibition of biofilm development
#73Methods of altering bone growth by administration of sost or wise antagonist or agonist
#74Method for improving cartilage repair and/or preventing cartilage degeneration in a joint
#75Method for producing a drug delivery system on the basis of polyelectrolyte complexes
#76PROMOTION OF WOUND HEALING
#77Medical device with coating that promotes endothelial cell adherence
#78Method for treating osteoarthritis
#79VHH for application in tissue repair, organ regeneration, organ replacement and tissue engineering
#80LIGAND-SPECIFIC INHIBITION OF ATTACHMENT OF IMMUNE CELLS TO IMPLANTABLE BIOMATERIALS
#81MEDICAL PRODUCT COMPRISING AN ACTIVE COATING
#82CYCLOOXYGENASE INHIBITOR AND CALCIUM CHANNEL ANTAGONIST COMPOSITIONS AND METHODS FOR USE IN UROLOGICAL PROCEDURES
#83Method and apparatus for delivering an agent to a kidney
#84Method and apparatus for delivering an agent to a kidney
#85METHODS OF ALTERING BONE GROWTH BY ADMINISTRATION OF SOST OR WISE ANTAGONIST OR AGONIST
#86METHODS AND COMPOSITIONS FOR PROMOTING WOUND HEALING
#87POLYMER COMPOSITIONS AND METHODS FOR THEIR USE
#88TISSUE ENGINEERED MYOCARDIUM AND METHODS OF PRODUCTION AND USES THEREOF
#89Implantable delivery vehicle for ocular delivery of muscarinic antagonists
#90TOPICAL FORMULATIONS OF FLAP INHIBITORS FOR THE TREATMENT OF DERMATOLOGICAL CONDITIONS
#91IMPLANT COATING WITH NUCLEIC ACIDS
#92MULTIMODAL ADHESION BARRIER
#93METHODS FOR GOVERNING TISSUE GROWTH
#94COMPOSITIONS AND METHODS FOR TREATING VASCULAR, AUTOIMMUNE, AND INFLAMMATORY DISEASES
#95PROGRAMMED-RELEASE, NANOSTRUCTURED BIOLOGICAL CONSTRUCT FOR STIMULATING CELLULAR ENGRAFTMENT FOR TISSUE REGENERATION
#96Method and apparatus for improving delivery of an agent to a kidney
#97Method and apparatus for improving delivery of an agent to a kidney
#98Treatment of dissection, aneurysm, and atherosclerosis using granzyme B inhibitors
#99Bone matrix compositions and methods
#100USE OF IMMOBILIZED ANTAGONISTS FOR ENHANCING GROWTH FACTOR CONTAINING BIOIMPLANT EFFECTIVENESS
#101Medical devices
#102DEGRADABLE POLYMERS INCORPORATING GAMMA-BUTYROLACTONE
#103Treatment of fibrotic conditions
#104Controlled release of growth factors and signaling molecules for promoting angiogenesis
#105FORMULATION FOR PREVENTING OR REDUCING BLEEDING AT A SURGICAL SITE
#106DRUG ELUTING BREAST IMPLANT COVER OR COATING
#107Methods and Devices for Preventing or Delaying Posterior Capsule Opacification
#108Use of Histamine H4 antagonist for the treatment of post-operative adhesions
#109Methods for treating osteoarthritis
#110OSTEOLYSIS TREATMENT
#111METHODS AND COMPOSITIONS FOR TEMPORAL RELEASE OF AGENTS FROM A BIODEGRADABLE SCAFFOLD
#112ELECTRICAL DEVICES AND ANTI-SCARRING AGENTS
#113SILK STENT GRAFTS
#114METHOD FOR IMPROVING CARTILAGE REPAIR AND/OR PREVENTING CARTILAGE DEGENERATION IN A JOINT
#115Medical Products That Release Pharmaceutically Active Substances
#116IMPLANTABLE SENSORS AND IMPLANTABLE PUMPS AND ANTI-SCARRING AGENTS
#117Nanoporous Drug Delivery System
#118Anti-no-reflow guide wire for vascular interventional procedures
#119Medical stent provided with inhibitors of atp synthesis
#120Methods and Compositions for Improving the Incorporation of Orthopaedic and Orthodontic Implants
#121Local Delivery of Matrix Metalloproteinase Inhibitors
#122Local Delivery of PAR-1 Antagonists to Treat Vascular Complications
#123METHODS AND COLLAGEN PRODUCTS FOR TISSUE REPAIR
#124Controlled Degradation of Magnesium Stents
#125A1 Adenosine Receptor Antagonist-Coated Implantable Medical Device
#126Process for coating a portion of an implantable medical device
#127SUTURES AND ANTI-SCARRING AGENTS
#128MEDICAL STENT PROVIDED WITH INHIBITORS OF TUMOR NECROSIS FACTOR-ALPHA
#129SOFT TISSUE IMPLANTS AND ANTI-SCARRING AGENTS
#130Modified phosphocalcic compound, injectable composition containing same
#131IMPLANT DEVICE FOR USE IN AN IMPLANT SYSTEM
#132MEDICAL ARTICLES FOR THE TREATMENT OF TUMORS
#133Anti-adhesion composites and methods of use thereof
#134Exotoxin Inhibitory Factor
#135LOCAL VASCULAR DELIVERY OF mTOR INHIBITORS IN COMBINATION WITH PEROXISOME PROLIFERATORS-ACTIVATED RECEPTOR STIMULATORS
#136Methods and compositions for promoting wound healing
#137NON-ABSORBENT ARTICLES CONTAINING ADDITIVES
#138UROLOGICAL DEVICES INCORPORATING COLLAGEN INHIBITORS
#139Medical devices incorporating collagen inhibitors
#140Method and apparatus for delivering an agent to a kidney
#141Enhancement Of The Calcium Sensing Receptor
#142Medical devices for delivering a therapeutic agent and method of preparation
#143Degradable polymers incorporating gamma-butyrolactone
#144Benign Prostatic Hyperplasia Treatments
#145SPACING DEVICES FOR RELEASING ACTIVE SUBSTANCES IN THE PARANASAL SINUS
#146METHODS FOR CONTRIBUTING TO CARDIOVASCULAR TREATMENTS
#147REDUCTION OF REACTIVE OXYGEN SPECIES IN CHRONIC WOUND MANAGEMENT
#148Terpolymers for controlled release of bioactive agents from implantable medical devices
#149Coronary stent having a surface of multi-layer immobilized structures
#150Product and Process for Inhibition of Biofilm Development
#151Methods of altering bone growth by administration of sost or wise antagonist or agonist
#152Urologic devices incorporating collagen inhibitors
#153Medical devices incorporating collagen inhibitors
#154FORMULATIONS AND DEVICES FOR TREATMENT OR PREVENTION OF NEURAL ISCHEMIC DAMAGE
#155METHODS FOR INHIBITING THE PRODUCTION OF TSST-1
#156Tissue graft materials containing biocompatible agent and methods of making and using same
#157Medical Devices for Delivering a Therapeutic Agent and Method of Preparation
#158Combination drug therapy for reducing scar tissue formation
#159STABILITY OF BIODEGRADABLE METALLIC STENTS, METHODS AND USES
#160Delayed-setting calcium phosphate pastes
#161Implantable devices containing nuclear receptor ligands for the treatment of vascular and related disorders
#162Medical devices and methods for local delivery of elastin-stabilizing compounds
#163Bone cutting template and method of treating bone fractures
#164Therapeutic agent carrier and method of treating bone fractures
#165Cyclooxygenase inhibitor and calcium channel antagonist compositions and methods for use in urological procedures
#166Method for In Vitro Assay of Demineralized Bone Matrix
#167Non-Absorbent Articles Containing Additives for Inhibiting the Production of TSST-1
#168Ultrasound activated medical device
#169Implantable medical device with pharmacologically active ingredient
#170Medical Device with Coating that Promotes Endothelial Cell Adherence
#171Bone matrix compositions and methods
#172Reduction of reactive oxygen species in chronic wound management
#173Local vascular delivery of PI3 kinase inhibitors alone or in combination with sirolimus to prevent restinosis following vascular injury
#174Platforms, particularly prostheses, having biologically active coverings
#175Medical devices with proteasome inhibitors for the treatment of restenosis
#176DRUG DEPOT FOR PARENTERAL, IN PARTICULAR INTRAVASCULAR, DRUG RELEASE
#177Combination drug therapy for reducing scar tissue formation
#178Electrical devices and anti-scarring agents
#179Method for treating osteoarthritis
#180Cyclooxygenase inhibitor and calcium channel antagonist compositions and methods for use in urological procedures
#181Methods and devices for preserving motion in an articulating prosthetic disc
#182Optimizing pharmacodynamics of therapeutic agents for treating vascular tissue
#183Medical implants and anti-scarring agents
#184Medical devices and compositions useful for treating or inhibiting restenosis
#185Polymer coating for medical devices
#186Medical devices for delivering a therapeutic agent and method of preparation
#187Absorbent articles for inhibiting the production of exoproteins
#188Method of implanting a sterile, active agent-coated material and composition made according to same
#189Musculo-skeletal implant having a bioactive gradient
#190Product and process for inhibition of biofilm development
#191Modified phosphocalcic compound, injectable composition containing same
#192Methods and compounds for treatment of aneurysmal tissue
#193Electrical devices and anti-scarring agents
#194Electrical devices and anti-scarring agents
#195Electrical devices and anti-scarring agents
#196Polymer compositions and methods for their use
#197Soft tissue implants and anti-scarring agents
#198Polymer compositions and methods for their use
#199Electrical devices and anti-scarring agents
#200Medical implants and anti-scarring agents
#201Soft tissue implants and anti-scarring agents
#202Electrical devices and anti-scarring agents
#203Polymer compositions and methods for their use
#204Soft tissue implants and anti-scarring agents
#205Implantable sensors and implantable pumps and anti-scarring agents
#206Polymer compositions and methods for their use
#207Implantable sensors and implantable pumps and anti-scarring agents
#208Polymer compositions and methods for their use
#209Medical implants and anti-scarring agents
#210Soft tissue implants and anti-scarring agents
#211Electrical devices and anti-scarring agents
#212Electrical devices and anti-scarring agents
#213Electrical devices and anti-scarring agents
#214Polymer compositions and methods for their use
#215Electrical devices and anti-scarring agents
#216Medical implants and anti-scarring agents
#217Medical implants and anti-scarring agents
#218Implantable sensors and implantable pumps and anti-scarring agents
#219Implantable sensors and implantable pumps and anti-scarring agents
#220Medical implants and anti-scarring agents
#221Soft tissue implants and anti-scarring agents
#222Implantable sensors and implantable pumps and anti-scarring agents
#223Polymer compositions and methods for their use
#224Polymer compositions and methods for their use
#225Medical implants and anti-scarring agents
#226Polymer compositions and methods for their use
#227Polymer compositions and methods for their use
#228Implantable sensors and implantable pumps and anti-scarring agents
#229Medical implants and anti-scarring agents
#230Implantable sensors and implantable pumps and anti-scarring agents
#231Implantable sensors and implantable pumps and anti-scarring agents
#232Medical implants and anti-scarring agents
#233Medicated tampon
#234Implantable sensors and implantable pumps and anti-scarring agents
#235Implantable sensors and implantable pumps and anti-scarring agents
#236Soft tissue implants and anti-scarring agents
#237Soft tissue implants and anti-scarring agents
#238Implantable sensors and implantable pumps and anti-scarring agents
#239Soft tissue implants and anti-scarring agents
#240Soft tissue implants and anti-scarring agents
#241Soft tissue implants and anti-scarring agents
#242Medical devices to treat or inhibit restenosis
#243Carbon nanotubules for storage of nitric oxide
#244Medical implants and anti-scarring agents
#245Electrical devices and anti-scarring agents
#246Medical implants and anti-scarring agents
#247Composition and method for bone regeneration
#248Medical implants and anti-scarring agents
#249Soft tissue implants and anti-scarring agents
#250Methods of inhibiting the TSST-1 production in gram positive bacteria
#251Resorption-controlled bone implants
#252Combination drug therapy for reducing scar tissue formation
#253Medical device with coating that promotes endothelial cell adherence